<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Cision Wire</title>
    <link>http://news.cision.com/</link>
    <description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description>
    <pubDate>Wed, 19 Jun 2013 15:59:38 GMT</pubDate>
    <image>
      <title>Cision Wire</title>
      <width>120</width>
      <height>32</height>
      <link>http://news.cision.com/</link>
      <url>http://news.cision.com/ui/images/CisionLogoSmall.gif</url>
    </image>
    <item>
      <title>Veloxis Pharmaceuticals A/S – annulment of warrants and registration of new Articles of Association pursuant thereto</title>
      <link>http://news.cision.com/veloxis-pharmaceuticals-a-s-g/r/veloxis-pharmaceuticals-a-s---annulment-of-warrants-and-registration-of-new-articles-of-association-,e378211</link>
      <guid isPermaLink="false">cision1346123</guid>
      <description><![CDATA[]]></description>
      <pubDate>Thu, 30 May 2013 10:10:11 GMT</pubDate>
    </item>
    <item>
      <title>European Medicines Agency (EMA) Accepts Veloxis’ Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients</title>
      <link>http://news.cision.com/veloxis-pharmaceuticals-a-s-g/r/european-medicines-agency--ema--accepts-veloxis--marketing-authorization-application--maa--for-lcp-t,e376447</link>
      <guid isPermaLink="false">cision1337931</guid>
      <description><![CDATA[]]></description>
      <pubDate>Tue, 21 May 2013 18:06:07 GMT</pubDate>
    </item>
    <item>
      <title>Final STRATO Clinical Study Data Demonstrates Potential for LCP-TacroTM to Improve Tacrolimus-Induced Tremors</title>
      <link>http://news.cision.com/veloxis-pharmaceuticals-a-s-g/r/final-strato-clinical-study-data-demonstrates-potential-for-lcp-tacrotm-to-improve-tacrolimus-induce,e376020</link>
      <guid isPermaLink="false">cision1335751</guid>
      <description><![CDATA[]]></description>
      <pubDate>Mon, 20 May 2013 06:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Veloxis Pharmaceuticals announces financial results for the first three months of 2013</title>
      <link>http://news.cision.com/veloxis-pharmaceuticals-a-s-g/r/veloxis-pharmaceuticals-announces-financial-results-for-the-first-three-months-of-2013,e375466</link>
      <guid isPermaLink="false">cision1332952</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 15 May 2013 15:12:11 GMT</pubDate>
    </item>
    <item>
      <title>Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for first Quarter 2013 – results from 1 January to 31 March, 2013</title>
      <link>http://news.cision.com/veloxis-pharmaceuticals-a-s-g/r/veloxis-pharmaceuticals-a-s-to-host-conference-call-announcing-interim-report-for-first-quarter-2013,e373544</link>
      <guid isPermaLink="false">cision1324593</guid>
      <description><![CDATA[]]></description>
      <pubDate>Tue, 07 May 2013 07:30:00 GMT</pubDate>
    </item>
    <item>
      <title>New Articles of Association</title>
      <link>http://news.cision.com/veloxis-pharmaceuticals-a-s-g/r/new-articles-of-association,e372399</link>
      <guid isPermaLink="false">cision1319461</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 01 May 2013 08:35:48 GMT</pubDate>
    </item>
    <item>
      <title>Veloxis Announces Submission of Marketing Authorization Application (MAA) to European Medicines Agency (EMA) for LCP-Tacro™ for Treatment of Kidney Transplant Patients</title>
      <link>http://news.cision.com/veloxis-pharmaceuticals-a-s-g/r/veloxis-announces-submission-of-marketing-authorization-application--maa--to-european-medicines-agen,e371704</link>
      <guid isPermaLink="false">cision1317153</guid>
      <description><![CDATA[]]></description>
      <pubDate>Mon, 29 Apr 2013 11:04:01 GMT</pubDate>
    </item>
    <item>
      <title>Veloxis Pharmaceuticals A/S - Passing of Ordinary General Meeting</title>
      <link>http://news.cision.com/veloxis-pharmaceuticals-a-s-g/r/veloxis-pharmaceuticals-a-s---passing-of-ordinary-general-meeting,e368829</link>
      <guid isPermaLink="false">cision1306022</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 17 Apr 2013 13:00:14 GMT</pubDate>
    </item>
    <item>
      <title>Notice to Convene Annual General Meeting</title>
      <link>http://news.cision.com/veloxis-pharmaceuticals-a-s-g/r/notice-to-convene-annual-general-meeting,e363964</link>
      <guid isPermaLink="false">cision1281207</guid>
      <description><![CDATA[]]></description>
      <pubDate>Fri, 22 Mar 2013 08:59:09 GMT</pubDate>
    </item>
    <item>
      <title>Warrant Programme - Registration of capital increase and new Articles of Association following warrant exercise</title>
      <link>http://news.cision.com/veloxis-pharmaceuticals-a-s-g/r/warrant-programme---registration-of-capital-increase-and-new-articles-of-association-following-warra,e360453</link>
      <guid isPermaLink="false">cision1264024</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 06 Mar 2013 12:41:06 GMT</pubDate>
    </item>
  </channel>
</rss>